Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

AbbVie Invests €150 million in New German Development Facility
European Pharmaceutical Manufacturer
Mon, 05/6/24 - 05:57 pm
Tags:
AbbVie, Germany, R&D, drug development
FDA Approval Fuels Boehringer’s Biosimilar Challenge to AbbVie’s Humira
BioSpace
Thu, 05/2/24 - 11:37 am
Tags:
Boehringer Ingelheim, Cyltezo, AbbVie, Huira, FDA, biosimilars
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes
Thu, 05/2/24 - 11:34 am
Tags:
CVS Caremark, AbbVie, Humira, biosimilars, Hyrimoz, Sandoz, PBMs
As Imbruvica bows out, AstraZeneca clinches early Calquence win in newly diagnosed MCL
Fierce Pharma
Thu, 05/2/24 - 11:31 am
Tags:
AbbVie, JNJ, Imbruvica, AstraZeneca, Calquence, mantle cell lymphoma
Trials to watch: Four ALS drugs to keep an eye on
Clinical Trials Arena
Tue, 04/30/24 - 06:34 pm
Tags:
ALS, clinical trials, Calico Life Sciences, AbbVie, ABBV-CLS-7262, AL-S Pharma, AP-101, Rapa Therapeutics, RAPA-501, Clene, CNMAu-8
Drugmaker AbbVie expects Humira volume erosion to worsen
Reuters
Sun, 04/28/24 - 11:18 pm
Tags:
AbbVie, Humira, PBMs, biosimilars
AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again
Fierce Pharma
Fri, 04/26/24 - 11:18 am
Tags:
AbbVie, Rinvoq, Regeneron, Sanofi, Dupixent, atopic dermatitis
AbbVie lifts profit forecast after Skyrizi sales beat expectations
Reuters
Fri, 04/26/24 - 11:12 am
Tags:
AbbVie, earnings
Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost
BioSpace
Fri, 04/26/24 - 11:09 am
Tags:
Cigna, Evernorth Health, Accredo, AbbVie, Humira, biosimilars
Emergence of ADCs as the “hot, new technology”
Pharmaphorum
Thu, 04/25/24 - 11:39 am
Tags:
antibody-drug conjugate, Immunogen, AbbVie, Seagen, Pfizer, cancer, M&A
AbbVie and Regenxbio’s ‘multibillion-dollar opportunity’ in vision loss gene therapy
Pharma Voice
Wed, 04/24/24 - 08:42 am
Tags:
Regenxbio, AbbVie, gene therapy, ABBV-RGX-314, wet age-related macular degeneration, diabetic retinopathy
AbbVie tops doctor ranking of immunology companies, handily beating Pfizer and J&J
BioSpace
Mon, 04/22/24 - 11:45 am
Tags:
physicians, AbbVie, JNJ, Pfizer, immunology
AbbVie, NeuroDerm Heat Up Levodopa Competition with New Data at AAN24
BioSpace
Mon, 04/22/24 - 11:40 am
Tags:
AbbVie, NeuroDerm, Levodopa, Parkinson's Disease, AAN
Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US
BioSpace
Fri, 04/19/24 - 11:28 am
Tags:
Alvotech, Teva Pharmaceutical, Humira, AbbVie, Simlandi, biosimilars
AbbVie touts Rinvoq win in giant cell arteritis, potentially teeing up another label expansion
Fierce Pharma
Thu, 04/18/24 - 11:15 am
Tags:
AbbVie, Rinvoq, clinical trials, giant cell arteritis
Humira biosimilar scripts take off
Axios
Tue, 04/16/24 - 07:42 am
Tags:
AbbVie, Humira, biosimilars, CVS Health
AbbVie Touts Long-Term Efficacy of Qulipta as Preventive Migraine Treatment
BioSpace
Mon, 04/15/24 - 11:06 am
Tags:
AbbVie, clinical trials, migraines, Qulipta
Rinvoq reclaims top Rx, OTC pharma brand crown
Medical Marketing and Media
Sun, 04/14/24 - 01:29 pm
Tags:
AbbVie, Rinvoq, OTC advertising
AbbVie-backed effort spotlights night symptoms of Parkinson’s
Medical Marketing and Media
Thu, 04/11/24 - 10:15 pm
Tags:
Parkinson's Disease, AbbVie, public awareness
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wed, 04/10/24 - 11:24 am
Tags:
oncology, M&A, AbbVie, Immunogen, Bristol Myers Squibb, Mirati Therapeutics, RayzeBio, Novartis, MorphoSys, AstraZeneca, Fusion Pharmaceuticals, JNJ, Ambrx, Gracell

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.